Skip to main content
Premium Trial:

Request an Annual Quote

UCSF Lands $2M to Support Molecular Medicine Partnership with China's Shantou University

NEW YORK (GenomeWeb News) – The University of California, San Francisco will use a $2 million grant from a Hong Kong-based private foundation to create a personalized genomic medicine research partnership with scientists in China, UCSF said on Friday.

UCSF said it plans to use the funding from the Li Ka Shing Foundation to partner with Shantou University, in Southeast China's Guangdong Province, and the foundation to launch three initial personalized medicine programs.

Under one program, the universities will create a biomedical knowledge network that will connect established clinical-pathological indexes with molecular profiles of diseases. They also plan to develop a program that will focus on systems pharmacology by combining new molecular technologies with traditional hypothesis-driven research approaches.

In another joint effort, UCSF, Shantou, and the foundation will bring together their researchers to launch international leadership exchanges and symposia.

These initial programs will serve as the springboard to other personalized medicine projects in the future, UCSF said.

This funding marks the first grant UCSF has received from the foundation, which is has contributed nearly $1 billion for education, healthcare, and cultural projects since its founding in 1980.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.